Drawing for DIESSE

USPTO serial 79287428

DIESSE

Reviewed by CopyMark Law Group

Reg. 6358398Status 700Renewal
Filing date
Status date
Registration date
May 25, 2021
Examiner
LAWRENCE, SUSAN KASTRINER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DIESSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anthony P. Venturino

Anthony P. Venturino Vorys, Sater, Seymour and Pease LLPP.O. Box 2255IPLAW@VORYSColumbus, OH 43216-2255

Goods and services

ClassDescriptionStatusFirst use
001chemical products, namely, chemical preparations for laboratory analysis, other than for medical or veterinary purposes; diagnostic preparations for scientific useACTIVE—
005Diagnostic preparations for medical purposes; cultures of microorganisms for medical and veterinary purposes; cultures of microorganisms for medical and veterinary use; bouillons for bacteriological cultures; media for bacteriological cultures; bacterial preparations for medical useACTIVE—
010diagnostic apparatus for medical purposes, namely, in-vitro diagnostic analyzers for the diagnosis and management of autoimmune status, cancer, endocrine disorders, infectious disease status, immune status, prenatal screening, sexually transmissible agents, transmissible agents, and for monitoring the erythrocyte sedimentation rate; apparatus for use in medical analysis, namely, for medical instruments analyzing and identifying antibodies, viral and bacterial antigens, hematology analyzers for medical diagnostic purposes; testing apparatus for medical purposes, namely, immunochemical testing apparatus for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 25, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 5, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 20, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 4, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 15, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 15, 2021FIMPFINAL DISPOSITION PROCESSED—
Aug 25, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 25, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 14, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 4, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Feb 4, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 4, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 4, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 15, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 15, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 15, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 14, 2020RFNTREFUSAL PROCESSED BY IB—
Jul 24, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 24, 2020RFRRREFUSAL PROCESSED BY MPU—
Jun 19, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 19, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2020DOCKASSIGNED TO EXAMINER—
Jun 15, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 11, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance